学科分类
/ 25
500 个结果
  • 简介:

  • 标签:
  • 简介:   [摘要 ] 目的 探讨美沙拉嗪联合双歧三联活菌治疗溃疡结肠炎疗效及其对炎因子影响。 方法 选取 2018年 1月~ 2020年 1月我院收治溃疡结肠炎患者 80例,随机分为两组,每组各 40例,两组患者均予常规对症治疗,同时两组均予美沙拉嗪缓释颗粒,观察组同时加用双歧三联活菌胶囊,治疗后比较两组患者治疗后临床疗效,以及两组患者治疗前后 TNF-α、 IL-10水平变化情况及两组患者治疗前后临床症状积分变化情况。结果 观察组治疗后总有效率为 95.00%,显著高于对照组总有效率 70.00%,两组疗效比较差异具有显著( P<0.05)。治疗后,两组患者因子 TNF-α、 IL-10水平较治疗前显著降低( P<0.05)。且观察组患者治疗后 TNF-α、 IL-10水平显著低于对照组( P<0.05)。观察组患者治疗后临床症状积分为( 2.56±0.85)分,与治疗前及对照组比较,差异有统计学意义( P<0.05)。 结论 美沙拉嗪联合双歧三联活菌治疗溃疡结肠炎疗效确切,且可以抑制炎症反应,值得临床推广和应用。     [关键词 ] 溃疡结肠炎 ;美沙拉嗪 ;双歧三联活菌 ;炎因子    [Abstract] Objective To investigate the efficacy of mesalazine combined with Bifid Triple Viable Bacteria in the treatment of ulcerative colitis and its influence on inflammatory factors. method Methods: 80 patients with ulcerative colitis in our hospital from January 2018 to January 2020 were selected and randomly divided into two groups, 40 cases in each group. Both groups were given conventional symptomatic treatment, while the two groups were given mesalazine sustained-release granules. The observation group was also given Bifid Triple Viable capsules. After treatment, the clinical efficacy of the two groups of patients after treatment, as well as TNF - α, IL-10 water before and after treatment, were compared between the two groups The changes of the two groups of patients before and after treatment of clinical symptoms integral changes. Results the total effective rate of the observation group was 95.00%, which was significantly higher than that of the control group (70.00%). There was a significant difference between the two groups (P < 0.05). After treatment, the levels of inflammatory factors TNF - α and IL-10 in the two groups were significantly lower than those before treatment (P < 0.05). The levels of TNF - α and IL-10 in the observation group were significantly lower than those in the control group (P < 0.05). The clinical symptom score of the observation group after treatment was (2.56 ± 0.85), and the difference was statistically significant (P < 0.05). Conclusion mesalazine combined with Bifid Triple Viable Bacteria is effective in the treatment of ulcerative colitis, and can inhibit inflammatory reaction, which is worthy of clinical promotion and application.

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:【摘要】目的:探究分析喉罩全身麻醉复合臂丛阻滞麻醉在肱骨干骨折手术患者中应用有效及安全。方法:选取本院2022年10月-2023年5月治疗60例肱骨干骨折手术患者作为研究对象,随机将其分为两组,即研究组、参照组,每组各30例。参照组单一使用臂丛阻滞麻醉,研究组使用喉罩全身麻醉复合臂丛阻滞麻醉,对其应用效果进行分析。结果:研究组T1、T2时段血流动力学水平低于参照组(P<0.05);两组不良反应率相比差异不大(P>0.05)。结论:喉罩全身麻醉复合臂丛阻滞麻醉应用到肱骨干骨折手术中时,有助于患者生命体征平稳,安全较高。

  • 标签: 肱骨干骨折 有效性 安全性 喉罩全身麻醉 臂丛阻滞麻醉